The solid progress of nanomedicine

Martins, J. P.; das Neves, J.; De La Fuente Freire, María; Celia, C.; Florindo, H.; Guenday-Tureli, N.; Popat, A.; Santos, J. L.; Sousa, F.; Schmid, R.; Wolfram, J.; Sarmento, B.; Santos, H. A.
Thumbnail
Estatísticas
Estatísticas
Identificadores
Identificadores
URI: http://hdl.handle.net/20.500.11940/16671
PMID: 32141035
ISSN: 2190-393X
Rexistro completo
Servizos
Servizos
RISMendeleyLinksolver
Visualización ou descarga de ficheiros
Visualización ou descarga de ficheiros
Data de publicación
2020
Título da revista
DRUG DELIVERY AND TRANSLATIONAL RESEARCH
Tipo de contido
Journal Article
DeCS
grupos focales | nanomedicina | humanos | neoplasias | National Cancer Institute (U.S.)
MeSH
National Cancer Institute (U.S.) | Humans | Nanomedicine | Focus Groups | Neoplasms
Resumo
This commentary article conveys the views of the board of the Nanomedicine and Nanoscale Delivery Focus Group of the Controlled Release Society regarding the decision of the United States National Cancer Institute (NCI) in halting funding for the Centers of Cancer Nanotechnology Excellence (CCNEs), and the subsequent editorial articles that broadened this discussion. Graphical abstract.
Atribución 4.0 Internacional
A non ser que se indique outra cousa, a licenza do ítem descríbese comoAtribución 4.0 Internacional